Translational Biomedicine

  • ISSN: 2172-0479
  • Journal h-index: 12
  • Journal CiteScore: 8.06
  • Journal Impact Factor: 1.0
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • Secret Search Engine Labs
  • ResearchGate
Share This Page


The Occurrence of a High Number of Lung Cancer Metastases is Consonant with the Proposed Theory of Erythrocyte Associated Necrosis Factor

Wilson IB Onuigbo

In this journal, I argued that, concerning cancer necrosis itself, which was personally named as the Erythrocyte Associated Necrosis Factor (EANF), it plays a significant role. Accordingly, it is necessary to weigh repeatedly any evidence, which crops up or becomes recognized, in order to confirm or confute any such subsisting hypothesis. Elsewhere, it was hypothesized that EANF positively explains the anomalous lack of contralateral deposits in the cases of lung cancer. This emerged right from the experiences of the medical masters of yester years. In this context, another working hypothesis is being brought forward, namely, that when EANF production is low, the resulting metastases tend to be high in number. In conclusion, just as dangerous bleeding brought death in the days of yore, and the discovery of the Coagulation Factor brought relief, let EANF become the harbinger of the cure of cancer itself be it in the lung or elsewhere.